Peripheral Arterial Disease: Features
Commentary
11/16/2022
Monica Majumdar, MD, MPH; Anahita Dua, MD, MS, MBA, FACS
Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Monica Majumdar, MD, MPH; Anahita Dua...
Can we delineate objective differences in responsiveness to antiplatelet medications between the sexes to explain why women with PAD have fewer risk factors yet higher rates of nonhealing and amputation?
Can we delineate objective differences in responsiveness to antiplatelet medications between the sexes to explain why women with PAD have fewer risk factors yet higher rates of nonhealing and amputation?
Can we delineate objective...
11/16/2022
Vascular Disease Management
OBL Corner
11/16/2022
Sarah Melvin, MSPH; Pradeep Nair, MD
Cardiovascular Institute of the South, Houma, Louisiana
Sarah Melvin, MSPH; Pradeep Nair, MD
...
A review of the safety, efficacy, and outcomes of lower extremity endovascular intervention in patients with symptomatic PAD.
A review of the safety, efficacy, and outcomes of lower extremity endovascular intervention in patients with symptomatic PAD.
A review of the safety,...
11/16/2022
Vascular Disease Management
Review
10/26/2022
Ramzan M. Zakir, MD; Jaime M. Rivera Babilonia, MD
Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
Ramzan M. Zakir, MD; Jaime M. Rivera ...
The authors review pedal artery revascularization, which has been associated with improved wound healing and limb salvage.
The authors review pedal artery revascularization, which has been associated with improved wound healing and limb salvage.
The authors review pedal artery...
10/26/2022
Vascular Disease Management
AMP 2022
10/15/2022
Eric Secemsky, MD
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Eric Secemsky, MD
Beth Israel Deaco...
Dr. Eric Secemsky discusses several of his presentations at AMP 2022.
Dr. Eric Secemsky discusses several of his presentations at AMP 2022.
Dr. Eric Secemsky discusses...
10/15/2022
Vascular Disease Management
Editor's Corner
10/12/2022
Craig Walker, MD, FACC, FACP
Cardiovascular Institute of the South, Houma, Louisiana
Craig Walker, MD, FACC, FACP
Card...
Dr. Walker comments on the article by Ujueta and Lamas, "Is There a Role for Edetate Disodium Chelation in PAD and Specifically CLTI?"
Dr. Walker comments on the article by Ujueta and Lamas, "Is There a Role for Edetate Disodium Chelation in PAD and Specifically CLTI?"
Dr. Walker comments on the...
10/12/2022
Vascular Disease Management
Video
10/12/2022
Craig Walker, MD, FACC, FACP
Cardiovascular Institute of the South, Houma, Louisiana
Craig Walker, MD, FACC, FACP
Card...
Watch Dr. Walker's commentary on further investigation of chelation therapy.
Watch Dr. Walker's commentary on further investigation of chelation therapy.
Watch Dr. Walker's commentary on...
10/12/2022
Vascular Disease Management
Commentary
10/12/2022
Francisco Ujueta, MD, MS1; Gervasio A. Lamas, MD1,2
1Columbia University Division of Cardiology, Mount Sinai Medical Center, Miami Beach, Florida; 2Department of Medicine, Mount Sinai Medical Center, Miami Beach, Florida
Francisco Ujueta, MD, MS1; Gervasio A...
In this commentary, the authors review edetate disodium chelation therapy and its use in patients with PAD and CLTI.
In this commentary, the authors review edetate disodium chelation therapy and its use in patients with PAD and CLTI.
In this commentary, the authors...
10/12/2022
Vascular Disease Management
AMP 2022
09/16/2022
Yolanda Bryce, MD
Memorial Sloan Kettering Cancer Center, New York, New York
Yolanda Bryce, MD
Memorial Sloan Ket...
Dr. Yolanda Bryce discusses her presentation at AMP 2022 on racial disparities in CLI outcomes and amputation rates.
Dr. Yolanda Bryce discusses her presentation at AMP 2022 on racial disparities in CLI outcomes and amputation rates.
Dr. Yolanda Bryce discusses her...
09/16/2022
Vascular Disease Management
AMP 2022
09/16/2022
Michael Lichtenberg, MD
Vascular Centre Clinic Arnsberg, Arnsberg, Germany
Michael Lichtenberg, MD
Vascular Cen...
Dr. Lichtenberg discusses some of his presentations at AMP 2022, which focus on lesion preparation and data from the Rotarex trial.
Dr. Lichtenberg discusses some of his presentations at AMP 2022, which focus on lesion preparation and data from the Rotarex trial.
Dr. Lichtenberg discusses some...
09/16/2022
Vascular Disease Management
AMP 2022
09/16/2022
Marianne Brodmann, MD
University of Graz, Graz, Austria
Marianne Brodmann, MD
University of ...
Dr. Marianne Brodmann discusses her presentations at AMP 2022, including one on the importance of diversity and inclusion in clinical trials.
Dr. Marianne Brodmann discusses her presentations at AMP 2022, including one on the importance of diversity and inclusion in clinical trials.
Dr. Marianne Brodmann discusses...
09/16/2022
Vascular Disease Management
